• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在HepG2和RAW 264.7细胞中鉴定曲古抑菌素A作为清道夫受体BI的新型转录上调因子。

Identification of trichostatin A as a novel transcriptional up-regulator of scavenger receptor BI both in HepG2 and RAW 264.7 cells.

作者信息

Bao Yi, Yang Yuan, Wang Li, Gao Lei, Jiang Wei, Wang Lifei, Si Shuyi, Hong Bin

机构信息

Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, 100050, China.

出版信息

Atherosclerosis. 2009 May;204(1):127-35. doi: 10.1016/j.atherosclerosis.2008.08.041. Epub 2008 Sep 11.

DOI:10.1016/j.atherosclerosis.2008.08.041
PMID:18930459
Abstract

Scavenger receptor class B type I (SR-BI) and its human homologue CLA-1 plays an important role in reverse cholesterol transport (RCT). Using a previously established cell-based CLA-1 up-regulator screening assay, one of the positive strains, 04-9179, presented potent activity in elevating CLA-1 transcriptional level. We report here the identification of an active compound 9179A as a known compound trichostatin A (TSA), and its effects on CLA-1/SR-BI expression both in HepG2 human hepatoma cells and RAW 264.7 murine macrophage cells in vitro. The results showed that the mRNA and protein level of CLA-1/SR-BI were significantly up-regulated by 9179A both in HepG2 and RAW 264.7 cells. Corresponding to this, the uptake of DiI-HDL by both cells and the efflux of [(3)H]cholesterol by RAW 264.7 cells were increased by 9179A in dose-dependent manner. ABCA1 was also increased but SR-A decreased by 9179A in RAW 264.7 cells. Using a combination of reporter assays with various deletion in CLA-1 promoter and electrophoretic mobility shift assay, we demonstrated that -419/-232 bp fragment of the CLA-1 promoter mediated the effects of 9179A (i.e., TSA). Together, these studies identified TSA as a novel up-regulator of CLA-1/SR-BI both in HepG2 and RAW 264.7 cells.

摘要

I型清道夫受体B类(SR-BI)及其人类同源物CLA-1在胆固醇逆向转运(RCT)中起重要作用。利用先前建立的基于细胞的CLA-1上调调节剂筛选试验,其中一个阳性菌株04-9179在提高CLA-1转录水平方面表现出强大的活性。我们在此报告一种活性化合物9179A的鉴定,它是一种已知化合物曲古抑菌素A(TSA),以及它在体外对HepG2人肝癌细胞和RAW 264.7小鼠巨噬细胞中CLA-1/SR-BI表达的影响。结果表明,9179A在HepG2和RAW 264.7细胞中均显著上调了CLA-1/SR-BI的mRNA和蛋白质水平。与此相应,9179A以剂量依赖方式增加了两种细胞对DiI-HDL的摄取以及RAW 264.7细胞中[(3)H]胆固醇的流出。在RAW 264.7细胞中,9179A还增加了ABCA1但降低了SR-A。通过结合使用CLA-1启动子各种缺失的报告基因分析和电泳迁移率变动分析,我们证明CLA-1启动子的-419/-232 bp片段介导了9179A(即TSA)的作用。总之,这些研究确定TSA是HepG2和RAW 264.7细胞中CLA-1/SR-BI的新型上调调节剂。

相似文献

1
Identification of trichostatin A as a novel transcriptional up-regulator of scavenger receptor BI both in HepG2 and RAW 264.7 cells.在HepG2和RAW 264.7细胞中鉴定曲古抑菌素A作为清道夫受体BI的新型转录上调因子。
Atherosclerosis. 2009 May;204(1):127-35. doi: 10.1016/j.atherosclerosis.2008.08.041. Epub 2008 Sep 11.
2
Identification of dehydroxytrichostatin A as a novel up-regulator of the ATP-binding cassette transporter A1 (ABCA1).鉴定去氢依泊汀 A 为三磷酸腺苷结合盒转运体 A1(ABCA1)的新型上调调节剂。
Molecules. 2011 Aug 25;16(9):7183-98. doi: 10.3390/molecules16097183.
3
Coffee consumption enhances high-density lipoprotein-mediated cholesterol efflux in macrophages.喝咖啡可增强巨噬细胞中高密度脂蛋白介导的胆固醇外流。
Circ Res. 2010 Mar 5;106(4):779-87. doi: 10.1161/CIRCRESAHA.109.206615. Epub 2010 Jan 14.
4
Characterization of the isoflavone pratensein as a novel transcriptional up-regulator of scavenger receptor class B type I in HepG2 cells.异黄酮草原黄芩素作为HepG2细胞中I型清道夫受体新型转录上调因子的特性研究
Biol Pharm Bull. 2009 Jul;32(7):1289-94. doi: 10.1248/bpb.32.1289.
5
Identification of novel human high-density lipoprotein receptor Up-regulators using a cell-based high-throughput screening assay.使用基于细胞的高通量筛选试验鉴定新型人类高密度脂蛋白受体上调剂。
J Biomol Screen. 2007 Mar;12(2):211-9. doi: 10.1177/1087057106297568. Epub 2007 Jan 26.
6
[In vitro effect and mechanistic study of compound E23869 on lipid metabolism].化合物E23869对脂质代谢的体外作用及机制研究
Yao Xue Xue Bao. 2016 Apr;51(4):563-72.
7
Rutaecarpine suppresses atherosclerosis in ApoE-/- mice through upregulating ABCA1 and SR-BI within RCT.吴茱萸次碱通过上调逆向胆固醇转运(RCT)过程中的ATP结合盒转运体A1(ABCA1)和清道夫受体BI(SR-BI)来抑制载脂蛋白E基因敲除(ApoE-/-)小鼠的动脉粥样硬化。
J Lipid Res. 2014 Aug;55(8):1634-47. doi: 10.1194/jlr.M044198. Epub 2014 Jun 7.
8
[The in vitro anti-atherosclerotic activity of compound E0869].化合物E0869的体外抗动脉粥样硬化活性
Yao Xue Xue Bao. 2015 Apr;50(4):440-6.
9
PAPP-A negatively regulates ABCA1, ABCG1 and SR-B1 expression by inhibiting LXRα through the IGF-I-mediated signaling pathway.PAPP-A 通过 IGF-I 介导的信号通路抑制 LXRα,从而负调控 ABCA1、ABCG1 和 SR-B1 的表达。
Atherosclerosis. 2012 Jun;222(2):344-54. doi: 10.1016/j.atherosclerosis.2012.03.005. Epub 2012 Mar 27.
10
Macrophage ABCA1 and ABCG1, but not SR-BI, promote macrophage reverse cholesterol transport in vivo.巨噬细胞中的ABCA1和ABCG1,而非SR-BI,在体内促进巨噬细胞的胆固醇逆向转运。
J Clin Invest. 2007 Aug;117(8):2216-24. doi: 10.1172/JCI32057.

引用本文的文献

1
Role of Gut Microbiome in Atherosclerosis: Molecular and Therapeutic Aspects.肠道微生物组在动脉粥样硬化中的作用:分子和治疗方面。
Curr Cardiol Rev. 2023;19(4):e020223213408. doi: 10.2174/1573403X19666230202164524.
2
The Protective Role of Butyrate against Obesity and Obesity-Related Diseases.丁酸盐对肥胖及其相关疾病的保护作用。
Molecules. 2021 Jan 28;26(3):682. doi: 10.3390/molecules26030682.
3
Butyrate protects against high-fat diet-induced atherosclerosis via up-regulating ABCA1 expression in apolipoprotein E-deficiency mice.
丁酸盐通过上调载脂蛋白E缺陷小鼠中的ABCA1表达来预防高脂饮食诱导的动脉粥样硬化。
Br J Pharmacol. 2020 Apr;177(8):1754-1772. doi: 10.1111/bph.14933. Epub 2020 Feb 12.
4
Targeting epigenetics and non-coding RNAs in atherosclerosis: from mechanisms to therapeutics.靶向动脉粥样硬化中的表观遗传学和非编码 RNA:从机制到治疗。
Pharmacol Ther. 2019 Apr;196:15-43. doi: 10.1016/j.pharmthera.2018.11.003. Epub 2018 Nov 13.
5
New role for histone deacetylase 9 in atherosclerosis and inflammation.组蛋白去乙酰化酶9在动脉粥样硬化和炎症中的新作用。
Arterioscler Thromb Vasc Biol. 2014 Sep;34(9):1798-9. doi: 10.1161/ATVBAHA.114.304295.
6
MicroRNAs 185, 96, and 223 repress selective high-density lipoprotein cholesterol uptake through posttranscriptional inhibition.微小 RNA185、96 和 223 通过转录后抑制选择性高密度脂蛋白胆固醇摄取。
Mol Cell Biol. 2013 May;33(10):1956-64. doi: 10.1128/MCB.01580-12. Epub 2013 Mar 4.
7
Salvianolic acid B inhibits macrophage uptake of modified low density lipoprotein (mLDL) in a scavenger receptor CD36-dependent manner.丹酚酸 B 通过清道夫受体 CD36 依赖性途径抑制巨噬细胞摄取修饰的低密度脂蛋白(mLDL)。
Atherosclerosis. 2012 Jul;223(1):152-9. doi: 10.1016/j.atherosclerosis.2012.05.006. Epub 2012 May 15.
8
Design, synthesis and biological evaluation of hydroxamic acid derivatives as potential high density lipoprotein (HDL) receptor CLA-1 up-regulating agents.设计、合成及生物评价作为潜在的高密度脂蛋白(HDL)受体 CLA-1 上调剂的羟肟酸衍生物。
Molecules. 2011 Nov 2;16(11):9178-93. doi: 10.3390/molecules16119178.
9
Identification of dehydroxytrichostatin A as a novel up-regulator of the ATP-binding cassette transporter A1 (ABCA1).鉴定去氢依泊汀 A 为三磷酸腺苷结合盒转运体 A1(ABCA1)的新型上调调节剂。
Molecules. 2011 Aug 25;16(9):7183-98. doi: 10.3390/molecules16097183.
10
Scavenger receptors and their potential as therapeutic targets in the treatment of cardiovascular disease.清道夫受体及其作为心血管疾病治疗靶点的潜力。
Int J Hypertens. 2010 Aug 17;2010:646929. doi: 10.4061/2010/646929.